APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pregabalin Capsule

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pregabalin Capsule Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025189 pages

Choose your research edition.

Industry ResearchPregabalin Capsule Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Pregabalin Capsule Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Pregabalin Capsule Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pregabalin Capsule Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Pregabalin Capsule Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pregabalin Capsule market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pregabalin Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pregabalin Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pregabalin Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pregabalin Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pregabalin Capsule include Wan Vee Pharm, Succeway Pharmaceuticals, Qilu Pharmaceutical, Pfizer, Stat Rx USA, Angita Pharma, Actavis Pharma and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pregabalin Capsule market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pregabalin Capsule and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pregabalin Capsule sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pregabalin Capsule market size, projected growth trends, production technologies, key applications, and end-use industries.

Pregabalin Capsule Segment by Company

Wan Vee Pharm

Succeway Pharmaceuticals

Qilu Pharmaceutical

Pfizer

Stat Rx USA

Angita Pharma

Actavis Pharma

Accord Healthcare

Pregabalin Capsule Segment by Type

75mg Capsule

50mg Capsule

25mg Capsule

Others

Pregabalin Capsule Segment by Application

Clinics

Hospitals

Others

Pregabalin Capsule Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregabalin Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pregabalin Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregabalin Capsule.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pregabalin Capsule market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pregabalin Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pregabalin Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pregabalin Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pregabalin Capsule Industry Trends Table 2. Pregabalin Capsule Industry Drivers Table 3. Pregabalin Capsule Industry Opportunities and Challenges Table 4. Pregabalin Capsule Industry Restraints Table 5. Global Pregabalin Capsule Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pregabalin Capsule Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pregabalin Capsule Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pregabalin Capsule Sales Market Share by Manufacturers Table 9. Global Pregabalin Capsule Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Pregabalin Capsule Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pregabalin Capsule Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pregabalin Capsule Manufacturers, Product Type & Application Table 13. Global Pregabalin Capsule Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pregabalin Capsule by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 75mg Capsule Table 17. Major Manufacturers of 50mg Capsule Table 18. Major Manufacturers of 25mg Capsule Table 19. Major Manufacturers of Others Table 20. Global Pregabalin Capsule Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Pregabalin Capsule Sales by Type (2021-2026) & (k units) Table 22. Global Pregabalin Capsule Sales by Type (2027-2032) & (k units) Table 23. Global Pregabalin Capsule Sales Market Share by Type (2021-2026) Table 24. Global Pregabalin Capsule Sales Market Share by Type (2027-2032) Table 25. Global Pregabalin Capsule Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Pregabalin Capsule Revenue by Type (2021-2026) & (k units) Table 27. Global Pregabalin Capsule Revenue by Type (2027-2032) & (k units) Table 28. Global Pregabalin Capsule Revenue Market Share by Type (2021-2026) Table 29. Global Pregabalin Capsule Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Hospitals Table 32. Major Manufacturers of Others Table 33. Global Pregabalin Capsule Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Pregabalin Capsule Sales by Application (2021-2026) & (k units) Table 35. Global Pregabalin Capsule Sales by Application (2027-2032) & (k units) Table 36. Global Pregabalin Capsule Sales Market Share by Application (2021-2026) Table 37. Global Pregabalin Capsule Sales Market Share by Application (2027-2032) Table 38. Global Pregabalin Capsule Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Pregabalin Capsule Revenue by Application (2021-2026) & (k units) Table 40. Global Pregabalin Capsule Revenue by Application (2027-2032) & (k units) Table 41. Global Pregabalin Capsule Revenue Market Share by Application (2021-2026) Table 42. Global Pregabalin Capsule Revenue Market Share by Application (2027-2032) Table 43. Global Pregabalin Capsule Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Pregabalin Capsule Sales by Region (2021-2026) & (k units) Table 45. Global Pregabalin Capsule Sales Market Share by Region (2021-2026) Table 46. Global Pregabalin Capsule Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Pregabalin Capsule Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Pregabalin Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Pregabalin Capsule Sales by Country (2021-2026) & (k units) Table 50. North America Pregabalin Capsule Sales by Country (2027-2032) & (k units) Table 51. Europe Pregabalin Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Pregabalin Capsule Sales by Country (2021-2026) & (k units) Table 53. Europe Pregabalin Capsule Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Pregabalin Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Pregabalin Capsule Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Pregabalin Capsule Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Pregabalin Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Pregabalin Capsule Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Pregabalin Capsule Sales by Country (2027-2032) & (k units) Table 60. Global Pregabalin Capsule Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Pregabalin Capsule Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Pregabalin Capsule Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Pregabalin Capsule Revenue Market Share by Region (2021-2026) Table 64. Global Pregabalin Capsule Revenue Market Share by Region (2027-2032) Table 65. Wan Vee Pharm Company Information Table 66. Wan Vee Pharm Business Overview Table 67. Wan Vee Pharm Pregabalin Capsule Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Wan Vee Pharm Pregabalin Capsule Product Portfolio Table 69. Wan Vee Pharm Recent Development Table 70. Succeway Pharmaceuticals Company Information Table 71. Succeway Pharmaceuticals Business Overview Table 72. Succeway Pharmaceuticals Pregabalin Capsule Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Succeway Pharmaceuticals Pregabalin Capsule Product Portfolio Table 74. Succeway Pharmaceuticals Recent Development Table 75. Qilu Pharmaceutical Company Information Table 76. Qilu Pharmaceutical Business Overview Table 77. Qilu Pharmaceutical Pregabalin Capsule Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Qilu Pharmaceutical Pregabalin Capsule Product Portfolio Table 79. Qilu Pharmaceutical Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Pregabalin Capsule Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Pfizer Pregabalin Capsule Product Portfolio Table 84. Pfizer Recent Development Table 85. Stat Rx USA Company Information Table 86. Stat Rx USA Business Overview Table 87. Stat Rx USA Pregabalin Capsule Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Stat Rx USA Pregabalin Capsule Product Portfolio Table 89. Stat Rx USA Recent Development Table 90. Angita Pharma Company Information Table 91. Angita Pharma Business Overview Table 92. Angita Pharma Pregabalin Capsule Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Angita Pharma Pregabalin Capsule Product Portfolio Table 94. Angita Pharma Recent Development Table 95. Actavis Pharma Company Information Table 96. Actavis Pharma Business Overview Table 97. Actavis Pharma Pregabalin Capsule Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Actavis Pharma Pregabalin Capsule Product Portfolio Table 99. Actavis Pharma Recent Development Table 100. Accord Healthcare Company Information Table 101. Accord Healthcare Business Overview Table 102. Accord Healthcare Pregabalin Capsule Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Accord Healthcare Pregabalin Capsule Product Portfolio Table 104. Accord Healthcare Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Pregabalin Capsule Distributors List Table 108. Pregabalin Capsule Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Pregabalin Capsule Product Image Figure 2. Global Pregabalin Capsule Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pregabalin Capsule Market Size (2021-2032) & (US$ Million) Figure 4. Global Pregabalin Capsule Sales (2021-2032) & (k units) Figure 5. Global Pregabalin Capsule Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pregabalin Capsule Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 75mg Capsule Image Figure 9. 50mg Capsule Image Figure 10. 25mg Capsule Image Figure 11. Others Image Figure 12. Global Pregabalin Capsule Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Pregabalin Capsule Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Pregabalin Capsule Sales Market Share by Type (2021-2032) Figure 15. Global Pregabalin Capsule Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Pregabalin Capsule Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pregabalin Capsule Revenue Market Share by Type (2021-2032) Figure 18. Clinics Image Figure 19. Hospitals Image Figure 20. Others Image Figure 21. Global Pregabalin Capsule Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Pregabalin Capsule Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Pregabalin Capsule Sales Market Share by Application (2021-2032) Figure 24. Global Pregabalin Capsule Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Pregabalin Capsule Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Pregabalin Capsule Revenue Market Share by Application (2021-2032) Figure 27. North America Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Pregabalin Capsule Sales Market Share by Country (2021-2032) Figure 29. U.S. Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Pregabalin Capsule Sales Market Share by Country (2021-2032) Figure 34. Germany Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Pregabalin Capsule Sales Market Share by Country (2021-2032) Figure 41. China Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Pregabalin Capsule Sales Market Share by Country (2021-2032) Figure 49. Brazil Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Pregabalin Capsule Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Pregabalin Capsule Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Pregabalin Capsule Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Pregabalin Capsule Revenue (2021-2032) & (US$ Million) Figure 60. North America Pregabalin Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Pregabalin Capsule Revenue (2021-2032) & (US$ Million) Figure 62. Europe Pregabalin Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Pregabalin Capsule Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Pregabalin Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Pregabalin Capsule Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Pregabalin Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Pregabalin Capsule Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pregabalin Capsule Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 75mg Capsule
  • 50mg Capsule
  • 25mg Capsule
  • Others
Applications
  • Clinics
  • Hospitals
  • Others
Companies covered
  • Wan Vee Pharm
  • Succeway Pharmaceuticals
  • Qilu Pharmaceutical
  • Pfizer
  • Stat Rx USA
  • Angita Pharma
  • Actavis Pharma
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pregabalin Capsule Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pregabalin Capsule Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pregabalin Capsule Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pregabalin Capsule Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pregabalin Capsule Market Dynamics
  1. 2.1 Pregabalin Capsule Industry Trends
  2. 2.2 Pregabalin Capsule Industry Drivers
  3. 2.3 Pregabalin Capsule Industry Opportunities and Challenges
  4. 2.4 Pregabalin Capsule Industry Restraints
3 Pregabalin Capsule Market by Manufacturers
  1. 3.1 Global Pregabalin Capsule Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pregabalin Capsule Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pregabalin Capsule Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pregabalin Capsule Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pregabalin Capsule Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pregabalin Capsule Manufacturers, Product Type & Application
  7. 3.7 Global Pregabalin Capsule Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pregabalin Capsule Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pregabalin Capsule Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pregabalin Capsule Tier 1, Tier 2, and Tier 3
4 Pregabalin Capsule Market by Type
  1. 4.1 Pregabalin Capsule Type Introduction
  2. 4.1.1 75mg Capsule
  3. 4.1.2 50mg Capsule
  4. 4.1.3 25mg Capsule
  5. 4.1.4 Others
  6. 4.2 Global Pregabalin Capsule Sales by Type
  7. 4.2.1 Global Pregabalin Capsule Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pregabalin Capsule Sales by Type (2021-2032)
  9. 4.2.3 Global Pregabalin Capsule Sales Market Share by Type (2021-2032)
  10. 4.3 Global Pregabalin Capsule Revenue by Type
  11. 4.3.1 Global Pregabalin Capsule Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pregabalin Capsule Revenue by Type (2021-2032)
  13. 4.3.3 Global Pregabalin Capsule Revenue Market Share by Type (2021-2032)
5 Pregabalin Capsule Market by Application
  1. 5.1 Pregabalin Capsule Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Others
  5. 5.2 Global Pregabalin Capsule Sales by Application
  6. 5.2.1 Global Pregabalin Capsule Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pregabalin Capsule Sales by Application (2021-2032)
  8. 5.2.3 Global Pregabalin Capsule Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pregabalin Capsule Revenue by Application
  10. 5.3.1 Global Pregabalin Capsule Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pregabalin Capsule Revenue by Application (2021-2032)
  12. 5.3.3 Global Pregabalin Capsule Revenue Market Share by Application (2021-2032)
6 Global Pregabalin Capsule Sales by Region
  1. 6.1 Global Pregabalin Capsule Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pregabalin Capsule Sales by Region (2021-2032)
  3. 6.2.1 Global Pregabalin Capsule Sales by Region (2021-2026)
  4. 6.2.2 Global Pregabalin Capsule Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pregabalin Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pregabalin Capsule Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pregabalin Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pregabalin Capsule Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pregabalin Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pregabalin Capsule Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pregabalin Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pregabalin Capsule Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pregabalin Capsule Revenue by Region
  1. 7.1 Global Pregabalin Capsule Revenue by Region
  2. 7.1.1 Global Pregabalin Capsule Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pregabalin Capsule Revenue by Region (2021-2026)
  4. 7.1.3 Global Pregabalin Capsule Revenue by Region (2027-2032)
  5. 7.1.4 Global Pregabalin Capsule Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pregabalin Capsule Revenue (2021-2032)
  8. 7.2.2 North America Pregabalin Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pregabalin Capsule Revenue (2021-2032)
  11. 7.3.2 Europe Pregabalin Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pregabalin Capsule Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pregabalin Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pregabalin Capsule Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pregabalin Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Wan Vee Pharm
  2. 8.1.1 Wan Vee Pharm Company Information
  3. 8.1.2 Wan Vee Pharm Business Overview
  4. 8.1.3 Wan Vee Pharm Pregabalin Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wan Vee Pharm Pregabalin Capsule Product Portfolio
  6. 8.1.5 Wan Vee Pharm Recent Developments
  7. 8.2 Succeway Pharmaceuticals
  8. 8.2.1 Succeway Pharmaceuticals Company Information
  9. 8.2.2 Succeway Pharmaceuticals Business Overview
  10. 8.2.3 Succeway Pharmaceuticals Pregabalin Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Succeway Pharmaceuticals Pregabalin Capsule Product Portfolio
  12. 8.2.5 Succeway Pharmaceuticals Recent Developments
  13. 8.3 Qilu Pharmaceutical
  14. 8.3.1 Qilu Pharmaceutical Company Information
  15. 8.3.2 Qilu Pharmaceutical Business Overview
  16. 8.3.3 Qilu Pharmaceutical Pregabalin Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical Pregabalin Capsule Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Pregabalin Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Pregabalin Capsule Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Stat Rx USA
  26. 8.5.1 Stat Rx USA Company Information
  27. 8.5.2 Stat Rx USA Business Overview
  28. 8.5.3 Stat Rx USA Pregabalin Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Stat Rx USA Pregabalin Capsule Product Portfolio
  30. 8.5.5 Stat Rx USA Recent Developments
  31. 8.6 Angita Pharma
  32. 8.6.1 Angita Pharma Company Information
  33. 8.6.2 Angita Pharma Business Overview
  34. 8.6.3 Angita Pharma Pregabalin Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Angita Pharma Pregabalin Capsule Product Portfolio
  36. 8.6.5 Angita Pharma Recent Developments
  37. 8.7 Actavis Pharma
  38. 8.7.1 Actavis Pharma Company Information
  39. 8.7.2 Actavis Pharma Business Overview
  40. 8.7.3 Actavis Pharma Pregabalin Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Actavis Pharma Pregabalin Capsule Product Portfolio
  42. 8.7.5 Actavis Pharma Recent Developments
  43. 8.8 Accord Healthcare
  44. 8.8.1 Accord Healthcare Company Information
  45. 8.8.2 Accord Healthcare Business Overview
  46. 8.8.3 Accord Healthcare Pregabalin Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Accord Healthcare Pregabalin Capsule Product Portfolio
  48. 8.8.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pregabalin Capsule Value Chain Analysis
  2. 9.1.1 Pregabalin Capsule Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pregabalin Capsule Production Mode & Process
  6. 9.2 Pregabalin Capsule Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pregabalin Capsule Distributors
  9. 9.2.3 Pregabalin Capsule Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst